Analysis of mTOR inhibition-involved pathway in ovarian clear cell adenocarcinoma.
Analysis of mTOR inhibition-involved pathway in ovarian clear cell adenocarcinoma.
复制标题
DOI:
10.1267/ahc.10029
复制
发表时间:
2011-04-28
影响因子:
2.4
通讯作者:
Mikami M
中科院分区:
文献类型:
--
作者:
Harasawa M;Yasuda M;Hirasawa T;Miyazawa M;Shida M;Muramatsu T;Douguchi K;Matsui N;Takekoshi S;Kajiwara H;Yoshiyuki Osamura R;Mikami M
This study was designed to clarify the mechanism of the mammalian target of rapamycin (mTOR)-hypoxia inducible factor-1 (HIF-1) pathway using the cultured cell strain derived from human ovarian clear cell adenocarcinoma (CCA). Everolimus (a derivative of rapamycin)-treated cells and non-treated cells did not show any difference in mTOR expression. But, phosphorylated-mTOR (p-mTOR) expression significantly decreased in the treated cells, and mTOR-related factors such as phosphorylated-4E-BP1 (p-4E-BP1), HIF-1α, and vascular endothelial growth factor (VEGF) in the downstream region of mTOR revealed a marked decrease in expression. The analysis of influences of the drug on the HIF-1α degradation system showed an increase in von-Hippel Lindau (VHL) expression in the treated cells. Increase of cleaved caspase-3, one of key factors involved in apoptosis, was also shown in the treated cells. In the next step, using nude mice implanted with RMG-1 cells, a decrease in tumor size was demonstrated in 4 of the 7 mice which were orally administered with everolimus. As a result, it was suggested that everolimus administration would be helpful as an anti-tumor therapy for CCA not only via down-regulation of p-mTOR but also degradation of HIF-1α by VHL and induction of apoptosis by cleaved caspase-3.
登录
查看更多内容
影响因子:
3.3
作者:
Osada, Ryosuke;Horiuchi, Akiko;Konishi, Ikuo
通讯作者:
Konishi, Ikuo
影响因子:
2.4
作者:
Miyajima K;Takekoshi S;Itoh J;Kakimoto K;Miyakoshi T;Osamura RY
通讯作者:
Osamura RY
DOI:
10.1073/pnas.92.11.4947
发表时间:
1995-05-23
影响因子:
11.1
作者:
CHEN, J;ZHENG, XF;SCHREIBER, SL
通讯作者:
SCHREIBER, SL
DOI:
10.1111/j.1525-1438.2006.00310.x
发表时间:
2006-01-01
影响因子:
4.8
作者:
Jiang, H;Feng, Y
通讯作者:
Feng, Y
影响因子:
64.5
作者:
Beuvink, I;Boulay, A;Thomas, G
通讯作者:
Thomas, G